Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Artera does not list a price
Free plan
Belong AI
Only Belong AI has one
Higher rating
Artera
4.4 against 4.2
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Artera
Belong AI
Our rating
4.4Better
4.2
Starts at
Not listed
Free
Free plan
No
YesBetter
Category
Healthcare AI
Healthcare AI
Plans
See pricing
Free
Key features
Multimodal AI trained on digitized biopsy images paired with clinical data
FDA De Novo authorization for the ArteraAI Prostate Test
FDA clearance for ArteraAI Breast digital pathology risk stratification
Results delivered in as little as two days after sample submission
Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines
Dave: conversational AI cancer mentor validated by oncologists
Sophie: AI mentor for multiple sclerosis patients
Tara: AI clinical-trial matching by medical profile and location
Trained on seven years of patient interaction data
Free Dave Community access tier
Pros
Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
Published clinical evidence showing improved outcome prediction versus existing risk models
Adopted by a meaningful share of US prostate cancer clinicians already
Medical validation from oncologists affiliated with ASCO and ESMO adds real clinical credibility
Free community tier keeps core support accessible regardless of ability to pay
Built on a decade of patient community data (Belong.Life founded 2015), not a cold-start chatbot
Cons
Not a self-serve software product; access runs through labs, clinicians, and insurance billing
Pricing is not public and varies by payer and region
Limited to prostate and breast cancer currently, not a general oncology platform
Exact DavePro subscription pricing is not published on the company site
An AI mentor cannot substitute for a patient's actual oncology care team
Sensitive health use case raises a higher bar for data-privacy scrutiny than general chatbots
Company
Artera, founded 2021
Belong.Life, founded 2015
Prices come from each vendor's pricing page, last checked 20260802. Check the vendor before you buy.
FAQ
Questions people ask
Is Artera better than Belong AI?
In our reviews Artera scores 4.4 and Belong AI scores 4.2. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. Belong AI: AI health mentor platform that gives cancer and MS patients conversational support validated by oncologists.